J Ruiz

Summary

Affiliation: Centre Hospitalier Universitaire Vaudois
Country: Switzerland

Publications

  1. ncbi [Management of diabetes: a priority for the European Union]
    Juan Ruiz
    Rev Med Suisse 2:1443. 2006
  2. doi Effects of a multifaceted psychiatric intervention targeted for the complex medically ill: a randomized controlled trial
    F Stiefel
    Service de Psychiatrie de Liaison, University Hospital of Lausanne, Lausanne, Switzerland
    Psychother Psychosom 77:247-56. 2008
  3. ncbi [Patient with type 2 diabetes: don't forget eating disorders!]
    Giacomo Gastaldi
    Division d endocrinologie, diabetologie et metabolisme, Departement de Medecine Interne, CHUV, 1011 Lausanne
    Rev Med Suisse 5:667-70. 2009
  4. ncbi [DIAfit, a Swiss program encouraging physical activity in patients with type 2 diabetes]
    Jardena Puder
    Service d endocrinologie, diabetologie et metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse 6:2100-2. 2010
  5. ncbi [Hypoglycemia in patients treated with an external insulin pump]
    Jean Christophe Laurent
    Service de Medecine Interne, CHUV, 1011 Lausanne
    Rev Med Suisse 7:166-9. 2011
  6. pmc Effects of paraoxonase activity and gene polymorphism on coronary vasomotion
    Vincent Dunet
    Department of Nuclear Medicine, Centre Hospitalier Universitaire Vaudois CHUV and University of Lausanne, Rue du Bugnon 46, Lausanne, 1011, Switzerland
    EJNMMI Res 1:27. 2011
  7. ncbi [Hypoglycemia and diabetes treatment: the return to normal glucose level is not always the best therapeutic strategy]
    J Ruiz
    Service d endocrinologie, diabetologie et metabolisme, CHUV, Lausanne
    Rev Med Suisse 9:1182, 1184-5. 2013
  8. ncbi [Diabetes]
    J Ruiz
    Service d endocrinologie, diabetologie et metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse 9:100-3. 2013
  9. ncbi [Diabetes mellitus]
    J Ruiz
    Service d endocrinologie, diabetologie et metabolisme, Departement de Medecine Interne, CHUV, 1011 Lausanne
    Rev Med Suisse 8:88-90. 2012
  10. ncbi [Type 2 diabetes, is it just a case of hyperglycemia? Confusion between the interests of science, humanity and the economy]
    Juan Ruiz
    Service d endocrinologie, diabetologie et metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse 5:1280-2. 2009

Collaborators

Detail Information

Publications44

  1. ncbi [Management of diabetes: a priority for the European Union]
    Juan Ruiz
    Rev Med Suisse 2:1443. 2006
  2. doi Effects of a multifaceted psychiatric intervention targeted for the complex medically ill: a randomized controlled trial
    F Stiefel
    Service de Psychiatrie de Liaison, University Hospital of Lausanne, Lausanne, Switzerland
    Psychother Psychosom 77:247-56. 2008
    ..This study evaluated a multifaceted psychiatric intervention targeted at the complex medically ill identified by means of the INTERMED, an instrument to assess case complexity...
  3. ncbi [Patient with type 2 diabetes: don't forget eating disorders!]
    Giacomo Gastaldi
    Division d endocrinologie, diabetologie et metabolisme, Departement de Medecine Interne, CHUV, 1011 Lausanne
    Rev Med Suisse 5:667-70. 2009
    ..To succeed in ED treatment, a multidisciplinary and specialised team in eating disorder is requested, however these patients are highly fragile and complex and therapeutic failure has to be feared...
  4. ncbi [DIAfit, a Swiss program encouraging physical activity in patients with type 2 diabetes]
    Jardena Puder
    Service d endocrinologie, diabetologie et metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse 6:2100-2. 2010
    ..Its objective is to allow the initiation of a structured physical activity in the setting of a pluridisciplinary team to promote a healthy lifestyle...
  5. ncbi [Hypoglycemia in patients treated with an external insulin pump]
    Jean Christophe Laurent
    Service de Medecine Interne, CHUV, 1011 Lausanne
    Rev Med Suisse 7:166-9. 2011
    ....
  6. pmc Effects of paraoxonase activity and gene polymorphism on coronary vasomotion
    Vincent Dunet
    Department of Nuclear Medicine, Centre Hospitalier Universitaire Vaudois CHUV and University of Lausanne, Rue du Bugnon 46, Lausanne, 1011, Switzerland
    EJNMMI Res 1:27. 2011
    ..abstract:..
  7. ncbi [Hypoglycemia and diabetes treatment: the return to normal glucose level is not always the best therapeutic strategy]
    J Ruiz
    Service d endocrinologie, diabetologie et metabolisme, CHUV, Lausanne
    Rev Med Suisse 9:1182, 1184-5. 2013
    ..These targets should not aim the physiological standards but to be adapted to patient's situation. Shared decision-making and consensus are the two pillars of this new strategy supported by the new ADA-EASD guidelines...
  8. ncbi [Diabetes]
    J Ruiz
    Service d endocrinologie, diabetologie et metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse 9:100-3. 2013
    ..Treatment guidelines for cardiovascular risk reduction in diabetic remains the last point to develop...
  9. ncbi [Diabetes mellitus]
    J Ruiz
    Service d endocrinologie, diabetologie et metabolisme, Departement de Medecine Interne, CHUV, 1011 Lausanne
    Rev Med Suisse 8:88-90. 2012
    ..This change of perspective should enable us to approach the chronic diseases differently. It is the objective of this review...
  10. ncbi [Type 2 diabetes, is it just a case of hyperglycemia? Confusion between the interests of science, humanity and the economy]
    Juan Ruiz
    Service d endocrinologie, diabetologie et metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse 5:1280-2. 2009
    ..It obliges to have a critical glance on the research often moved by economic issues and gives to the center a humanistic approach based on the therapeutic relation...
  11. ncbi [The DREAM of diabetes prevention]
    Juan Ruiz
    Service d endocrinologie, diabetologie et metabolisme, Département de médecine interne CHUV, Lausanne
    Rev Med Suisse 3:132, 134-6. 2007
    ..The ramipril had no preventive effect for the prevention of type 2 diabetes but induced a higher frequency of return towards the normoglycaemia. This treatment can be recommended for these high risk subjects...
  12. ncbi [The Polypill: between myths and reality in the treatment of type 2 diabetes mellitus]
    J Ruiz
    Service d endocrinologie, diabétologie et métabolisme CHUV, 101 Lausanne
    Rev Med Suisse 2:1480-2, 1484-5. 2006
    ..Other approaches based on the change of lifestyle seem so effective. Nevertheless, to have a really effective approach the therapeutic educational dimension should be also included in the basic strategy...
  13. ncbi [Trends in diabetes]
    J Ruiz
    Service d endocrinologie, diabetologie et metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse 4:116, 118-21. 2008
    ..Post-Steno 2 was presented at the European congress diabetes. These new data confirm that the intensified treatment of all cardiovascular factors risk allows a major reduction of cardiovascular mortality after 13.3 years...
  14. ncbi [Functional insulin therapy courses adapted to the patient's reality]
    J Ruiz
    Service d endocrinologie, diabetologie et metabolisme, CHUV, Lausanne
    Rev Med Suisse 7:1255-6, 1258-9. 2011
    ..The acronym ASKAR refers to the five components of a person's experience: Action, Situation, Knowledge, Attitude and Resource. Working on these five components is a way for patients to improve their management of uncertainty...
  15. ncbi [Metabolic syndrome, diabetes mellitus and vulnerability: a syndemic approach of chronic diseases]
    Juan Ruiz
    Service d endocrinologie, diabétologie et métabolisme EDM, CHUV, 1011 Lausanne
    Rev Med Suisse 6:2205-8. 2010
    ..The healthcare networks centered on the management of the costs of health should not forget the socio-cultural dimension, unless wanting to select the good cases...
  16. ncbi [Are pioglitazone and fenofibrate effective for the prevention of cardiovascular disease in type 2 diabetes?]
    J Ruiz
    Service d endocrinologie, diabetologie et metabolisme, Departement de Medecine Interne, CHUV, IO11 Lausanne
    Rev Med Suisse 2:116-8. 2006
    ..035). These studies reveal the difficulties and the complexity of the secondary prevention of atherosclerosis for patients already treated with effective molecules...
  17. ncbi [Treatments for cardiovascular risk factors and screening for coronary artery disease in type 2 diabetes mellitus]
    J Ruiz
    Service d endocrinologie, diabetologie et metabolisme, CHUV et Universite de Lausanne
    Rev Med Suisse 6:1176-8, 1180-1. 2010
    ..The long term studies reveal that more realistic objectives remain beneficial...
  18. ncbi [Patient education: the way for long-term follow up]
    J Ruiz
    Service d endocrinologie, diabetologie et metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse 4:1405-6, 1408-9. 2008
    ..We summarize here our reflexive process in the course of an interdisciplinary team gathering social sciences, art and medicine...
  19. ncbi [Transition from acute inpatient to chronic outpatient diabetes care: an symbolic situation]
    M Egli
    Service d endocrinologie, diabetologie et metabolisme, Département de médecine interne CHUV, 1011 Lausanne
    Rev Med Suisse 7:1260, 1262-6. 2011
    ..As in other complex conditions, deficiencies in this field are associated with increased errors and costs, which can be improved through interventions targeting inpatient to outpatient transition...
  20. ncbi [Risk perception and communication: from diabetes to cardiovascular diseases]
    F Gianinazzi
    Service de Medecine Interne, Hôpital d Yverdon, Yverdon les Bains
    Rev Med Suisse 6:1182-4, 1186-7. 2010
    ....
  21. ncbi [What strategy for the screening of coronary artery disease in type 1 diabetes?]
    S Comte-Perret
    Service d endocrinologie, diabetologie et metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse 7:1244-6, 1248-9. 2011
    ..Given the lack of prospective studies evaluating screening benefit for silent coronary artery disease in type 1 diabetes patients, screening strategies should be assessed depending on the context...
  22. ncbi [Diabetology]
    Marc Egli
    Service d endocrinologie, diabétologie et métabolisme CHUV, 1011 Lausanne
    Rev Med Suisse 5:101-5. 2009
    ..These findings emphasize the need for an individualized approach of type 2 diabetic patients, aiming at the best possible control of all risk factors while minimizing the risk of hypoglycemia...
  23. ncbi [Which role for self-monitoring of blood glucose in type 2 diabetes?]
    Marc Egli
    Service d endocrinologie, diabetologie et metabolisme, Departement de Medecine Interne, CHUV, 1011 Lausanne
    Rev Med Suisse 5:1254-8. 2009
    ..To be appropriate this strategy cannot be based on the health care professionals' view on diabetes only. It rather has to be tailored to the individual patient's needs through an ongoing process of shared reflection with him...
  24. ncbi [Metabolic dysfunction and chronic stress: a new sight at "diabesity" pandemic]
    Giacomo Gastaldi
    Service d endocrinologie, diabetologie et metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse 5:1273-7. 2009
    ..To decrease allostatic load, practitioners can rely on therapeutic relation. Therapeutic education is one of the skill that can be use to create therapeutic relation...
  25. ncbi [Diabetes. Perspectives on the management of diabetes in 2010.]
    Marc Egli
    Service d endocrinologie, diabétologie et métabolisme Département de médecine interne, CHUV, 1011 Lausanne
    Rev Med Suisse 7:113-6. 2011
    ..The process of their choice has to include the quest for a shared vision with the patient who is in charge of diabetes management in daily life...
  26. ncbi [Preventing cardiovascular disease in type 2 diabetes. From evidence based medicine to patient based reality]
    G Arnold-Kunz
    Service de Diabetologie, Endocrinologie et Metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse 3:1456-8, 1460-2. 2007
    ..We need to take into account of their beliefs and their priorieties to seek actively the causes of non compliance and beyond evidence based medicine to accompany them in choosing the interventions they are ready to invest themself...
  27. ncbi [What can be expected from the GLP-1 agonists and DPP-4 inhibitors in the treatment of type 2 diabetes?]
    M Egli
    Service d endocrinologie, diabétologie et métabolisme CHUV, 1011 Lausanne
    Rev Med Suisse 3:1449-50, 1453-5. 2007
    ..In the absence of relevant clinical studies, their long-term efficacy is currently unknown, as well as the clinical impact of other promising effects like beta-cell preservation...
  28. ncbi [Preventing type 2 diabetes complications: from evidence-based recommendations to patient-based reality]
    S Beer
    Service d endocrinologie, diabetologie et metabolisme, Departement de Medecine Interne, CHUV, 1011 Lausanne
    Rev Med Suisse 1:1492-8. 2005
    ..Above all, the management of these patients implies involving them as the main actors of their disease and treatments. This necessitates to take into account the beliefs and to actively seek the obstacles to therapeutic adherence...
  29. ncbi [Will the theory of metabolic memory change our therapeutic strategies in the face of type 2 diabetes?]
    J Ruiz
    Service d endocrinologie, diabetologie et metabolisme, Departement de Medecine Interne, CHUV, 1011 Lausanne
    Rev Med Suisse 1:1485-6, 1488-90. 2005
    ..Therapeutic approach based on the tendencies to hyperglycemia could improve the prevention of the diabetic vascular complications...
  30. ncbi [Oral anti-diabetic agents: update]
    J Ruiz
    Division d endocrinologie, diabétologie et du metabolisme, CHUV, Bugnon 46, 1011 Lausanne
    Rev Med Suisse Romande 121:655-61. 2001
    ..This review describes how to use oral antidiabetic agents: sulfonylurea, glinide, biguanide, alpha-glucosidase inhibitors and glitazone...
  31. ncbi [Diabetes]
    M Egli
    Service d endocrinologie, diabetologie et metabolisme, Departement de Medecine Interne, CHUV, 1011 Lausanne
    Rev Med Suisse 6:100, 102-4. 2010
    ..No conclusive evidence for an increased risk of cancer associated with insulin glargin remains when taking into account all the data currently available on this topic...
  32. ncbi [The inefficacy of glycemic control in the hospitalized patient: origins and solutions]
    M Egli
    Service d endocrinologie, diabetologie et metabolisme, CHUV, 1011I Lausanne
    Rev Med Suisse 4:1398-400, 1402-4. 2008
    ..This programme needs to be integrated in a systemic approach, which takes the professionals' context in account...
  33. ncbi [How can we give quick yet relevant nutritional advice in our daily medical practice?]
    S Girardin
    Service d endocrinologie, diabetologie et metabolisme, PMU, 1011 Lausanne
    Rev Med Suisse 3:1432-4, 1436. 2007
    ..We suggest an intervention guide so that the nutritional education work undertaken in an ambulatory consultation may then lead to dietetic management...
  34. ncbi [Gestational diabetes: what follow-up after delivery?]
    S Beer
    Service d endocrinologie, diabetologie et metabolisme, Département de médecine interne CHUV et PMU, 1011 Lausanne
    Rev Med Suisse 2:1468-72. 2006
    ..Specific preventive strategies to this population at high risk must be created and evaluated...
  35. ncbi [Charcot osteoarthropathy: don't miss it!]
    G Gastaldi
    Service d endocrinologie, diabetologie et metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse 9:1212, 1214-20. 2013
    ..The scientific evidences aren't strong enough to recommend bisphosphonates or acute surgical treatment. Surgery is unanimusly recommended to prevent secondary ulceration...
  36. ncbi [Metabolic syndrome, a mitochondrial disease?]
    G Gastaldi
    Service d endocrinologie, diabetologie et metabolisme, Departement de Medecine Interne, CHUV, Lausanne
    Rev Med Suisse 4:1387-8, 1390-1. 2008
    ....
  37. ncbi [Intensive care of type 2 diabetes: what does the STENO 2 study teach us?]
    Juan Ruiz
    Division d endocrinologie, diabétologie et du metabolisme, CHUV, 1011 Lausanne
    Rev Med Suisse Romande 124:125-7. 2004
    ....
  38. doi Cytomegalovirus infection and new-onset post-transplant diabetes mellitus
    En Ling Leung Ki
    Transplantation Center, Institute of Microbiology, and Service of Endocrinology, CHUV, Lausanne, Switzerland
    Clin Transplant 22:245-9. 2008
    ..These findings suggest that CMV infection after organ transplantation may be associated with concurrent PTDM. The distinct causative relationship is yet to be determined...
  39. ncbi Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation
    Paulino Vigil-De Gracia
    Department of Gynecology and Obstetrics, Obstetric Intensive Care, Complejo Hospitalario AAM Caja de Seguro Social, PO Box 873224, ZIP 7, Panama, Panama
    Eur J Obstet Gynecol Reprod Biol 107:24-7. 2003
    ..Timing of delivery is difficult to judge in preeclampsia...
  40. ncbi Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy
    John O Prior
    Division of Nuclear Medicine, Centre Hospitalier Universitaire Vaudois CHUV University Hospital, 1011, Lausanne, Switzerland
    Eur J Nucl Med Mol Imaging 32:60-9. 2005
    ..In this study we therefore sought (a) to determine the prevalence of symptomatic and silent perfusion defects in diabetic patients with suspected CAD and (b) to characterise the eventual predictors of abnormal perfusion...
  41. ncbi Diabetic neuropathy is a more important determinant of baroreflex sensitivity than carotid elasticity in type 2 diabetes
    Juan Ruiz
    Department of Endocrinology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    Hypertension 46:162-7. 2005
    ..Therefore, neuropathy is a more significant determinant of baroreflex sensitivity than carotid artery elasticity in patients with type 2 diabetes...
  42. ncbi EIF4A2 is a positional candidate gene at the 3q27 locus linked to type 2 diabetes in French families
    Claire Cheyssac
    CNRS UMR 8090, Biology Institute and Pasteur Institute of Lille, 1 rue du Professeur Calmette, BP 245, 59019 Lille, France
    Diabetes 55:1171-6. 2006
    ..The potential role of EIF4A2 in glucose homeostasis and its putative contribution to type 2 diabetes in the presence of metabolic stress will require further investigation...
  43. ncbi Postprandial modulation of serum paraoxonase activity and concentration in diabetic and non-diabetic subjects
    Sandra Beer
    Division of Endocrinology, Diabetes and Metabolism, University Hospital, Lausanne, Switzerland
    Nutr Metab Cardiovasc Dis 16:457-65. 2006
    ..To analyse the HDL associated anti-oxidant enzyme paraoxonase-1, during postprandial hyperlipaemia...
  44. ncbi Towards the end of the Spanish paradox?
    Juan Ruiz
    Soz Praventivmed 51:79. 2006